These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Combined chemo-radiation and hyperthermia for locally advanced soft tissue sarcoma: response and toxicity. Uno T, Itami J, Kato H. Anticancer Res; 1995; 15(6B):2655-7. PubMed ID: 8669842 [Abstract] [Full Text] [Related]
5. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS). Maurel J, Fra J, López-Pousa A, García del Muro X, Balañá C, Casado A, Martín J, Martínez-Trufero J, de las Peñas R, Buesa JM, Spanish Group for Research on Sarcomas (GEIS). Cancer; 2004 Apr 01; 100(7):1498-506. PubMed ID: 15042685 [Abstract] [Full Text] [Related]
6. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas. Hegazy MA, Kotb SZ, Sakr H, El Dosoky E, Amer T, Hegazi RA, Farouk O. Ann Surg Oncol; 2007 Feb 01; 14(2):568-76. PubMed ID: 17094027 [Abstract] [Full Text] [Related]
7. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG). Toma S, Tucci A, Villani G, Carteni G, Spadini N, Palumbo R. Anticancer Res; 2000 Feb 01; 20(1B):485-91. PubMed ID: 10769710 [Abstract] [Full Text] [Related]
8. Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma. Schütte J, Mouridsen HT, Steward W, Santoro A, van Oosterom AT, Somers R, Blackledge G, Verweij J, Dombernowsky P, Thomas D. Cancer Chemother Pharmacol; 1993 Feb 01; 31 Suppl 2():S204-9. PubMed ID: 8453699 [Abstract] [Full Text] [Related]
10. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas. Toma S, Palumbo R, Canavese G, Albanese E, Cantoni E, Barisone A, Reggiardo G, Rosso R, Santi L. Cancer Chemother Pharmacol; 1993 Feb 01; 31 Suppl 2():S222-7. PubMed ID: 8453703 [Abstract] [Full Text] [Related]
16. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen. Schütte J, Kellner R, Seeber S. Cancer Chemother Pharmacol; 1993 Feb 01; 31 Suppl 2():S194-8. PubMed ID: 8453697 [Abstract] [Full Text] [Related]
17. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY, European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol; 2007 Jul 20; 25(21):3144-50. PubMed ID: 17634494 [Abstract] [Full Text] [Related]
18. Feasibility study of postoperative adjuvant chemotherapy and radiotherapy for soft-tissue sarcoma. Fuchs R, Schadeck-Gressel C, Makoski HB, von Andrian-Werburg HF, Knieriem HJ, Westerhausen M. Cancer Chemother Pharmacol; 1993 Jul 20; 31 Suppl 2():S199-203. PubMed ID: 8453698 [Abstract] [Full Text] [Related]
19. Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989-1999). Hahn KA, Endicott MM, King GK, Harris-King FD. J Am Vet Med Assoc; 2007 Sep 01; 231(5):742-5. PubMed ID: 17764436 [Abstract] [Full Text] [Related]
20. Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas. Comandone A, Bretti S, Bertetto O, Oliva C, Bergnolo P, Bumma C. Anticancer Res; 2000 Sep 01; 20(3B):2077-80. PubMed ID: 10928155 [Abstract] [Full Text] [Related] Page: [Next] [New Search]